PDCD1 and extranodal nasal NK/T cell lymphoma: Romidepsin combined with hPD1 antibody is superior to PD1 antibody alone in the treatment of NK-T cell lymphoma, but it is similar to romidepsin single agent, either in different dosages or sequence